As of 2026-04-05, the Fair Value of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is -7.17 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.72 USD, the upside of Reviva Pharmaceuticals Holdings, Inc. is -1,095.69%.
With the market price of 0.72 USD and our fair value calculation, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is not a good investment. Investing in RVPH stocks now will result in a potential loss of 1,095.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -8.52 | -28.26 | -39.26 | -29.92 | -19.86 | -25.17 |
| YoY growth | -125.24% | -231.63% | -38.92% | 23.79% | 33.60% | -67.68% |
| Market Cap (mil) | 9.98 |
| P/E | |
| Forward P/E |
| EPS | -1.43 |
| Avg earnings growth rate | -67.68% |
| TTM earnings | -19.86 |